Inactive Instrument

Medmira Inc Share Price Toronto S.E.

Equities

MIR

CA58501R1029

Advanced Medical Equipment & Technology

Financials

Sales 2022 10L 7L 5.81Cr Sales 2023 4L 3L 2.64Cr Capitalization 5.93Cr 4.33Cr 361.68Cr
Net income 2022 -10L -7L -6.1Cr Net income 2023 -20L -14.61L -12Cr EV / Sales 2022 101 x
Net Debt 2022 87.66L 64.03L 53Cr Net Debt 2023 1Cr 73.3L 61Cr EV / Sales 2023 160 x
P/E ratio 2022
-41.7 x
P/E ratio 2023
-21.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 30.59%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Founder - 01/93/01
Director of Finance/CFO - 28/10/28
Director/Board Member 60 01/07/01
Members of the board TitleAgeSince
Founder - 01/93/01
Director/Board Member 60 01/07/01
Director of Finance/CFO - 28/10/28
More insiders
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.
More about the company